Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2021.02.19.21252089: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: Study population, study design and recruitment: The ethical committee (EC) of the Medical University of Innsbruck approved the studies, baseline (Ischgl 1) with EC numbers: 1100/2020 and 1111/2020, which took place between April 21st and 27th, 2020 and follow-up (Ischgl 2) with EC number: 1330/2020, which took place between November 2nd and 8th, 2020. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable The covariates used to calculate the Mahalanobis distance were population size, settlement area per square km, share of female population, share of people under 16 years, share of people older than 65 … SciScore for 10.1101/2021.02.19.21252089: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IACUC: Study population, study design and recruitment: The ethical committee (EC) of the Medical University of Innsbruck approved the studies, baseline (Ischgl 1) with EC numbers: 1100/2020 and 1111/2020, which took place between April 21st and 27th, 2020 and follow-up (Ischgl 2) with EC number: 1330/2020, which took place between November 2nd and 8th, 2020. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable The covariates used to calculate the Mahalanobis distance were population size, settlement area per square km, share of female population, share of people under 16 years, share of people older than 65 years, number of commuters, share of people with tertiary education, and hotel bed capacity. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources For serostatus d and a individuals were considered as seropositive when they had neutralizing antibodies ≥1:16. Avidity of SARS-CoV-2-specific anti-S IgG: A kit was used according to manufactures instructions to determine of the avidity of anti-S antibodies (Euroimmun AG, Lübeck, Germany, REF: EI 2606-9601 G). anti-S IgGsuggested: Noneanti-Ssuggested: NoneFor the detection of remaining antibody, 100 µl of peroxidase-conjugated anti-human IgG were added, incubated for another 30 minutes at 37°C and plates were subsequently washed. anti-human IgGsuggested: NoneExperimental Models: Cell Lines Sentences Resources Shortly, VSVΔG-GFP virus was produced on 293T cells stably expressing a C-terminally truncated version of SARS-CoV-2 spike (Wuhan variant). 293Tsuggested: NCBI_Iran Cat# C498, RRID:CVCL_0063)Four-fold serial dilutions of heat-inactivated plasma were pre-incubated with virus for 1 h at 37°C and subsequently used to infect 293T-ACE2 cells seeded the previous day. 293T-ACE2suggested: RRID:CVCL_YZ65)Software and Algorithms Sentences Resources Additionally, each plasma was tested for anti-SARS-CoV-2-N-protein IgG (anti-N IgG) with the Abbott SARS-CoV-2 IgG immunoassay on the ARCHITECT i2000SR system (Abbott, Illinois, Abbottsuggested: (Abbott, RRID:SCR_010477)Statistical analysis: Statistical analyses were performed in Stata 16.1 (StataCorp. 2019. Stata Statistical Software: StataCorpsuggested: (Stata, RRID:SCR_012763): StataCorp LLC) and GraphPad Prism version 8.2.0 and 9 (GraphPad Software, Inc., La Jolla, CA, USA). GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-